comparemela.com

Edulla Ossea News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Do No Harm: What Smoldering Myeloma Teaches Us

Manni Mohyuddin, MD, highlights how he treats smoldering multiple myeloma.

Roberta kyleMultiple myelomaPlasma cell myelomaAlignant neoplasiaAlignant neoplasmSmoldering multiple myelomaMoldering multiple myeloma smmX rayBone densityBone mineral densityBone marrowEdulla osseaCancer riskKidney cancerAdrenal cancerBiologic therapy

Oncology Practice and Lab to Pay $4 Million in Kickback Case

San Antonio–based healthcare providers have agreed to pay over $4 million in civil settlements to resolve allegations of violating the False Claims Act through an unlawful kickback arrangement.

United statesSan antonioJayasree raoSlavisa gasicUs department of healthHuman services office of inspectorUs department of justiceOncology san antonioCorepath laboratoriesFalse claimsPath laboratoriesOncology sanAnti kickback statuteCharge jasonHuman services officeInspector general

Proinflammatory Diet May Prompt Worse Pain Course in Knee OA

Long-term data suggested a role of diet in persistence of knee pain but not structural changes.

Canchen maArthritis care researchUniversity of tasmaniaWestern ontarioMcmaster universities osteoarthritis indexFood frequency questionnaireArthritis careOsteoarthritis generalized oa djd degenerative joint disease arthritis generalisedOsteoarthritis oaPain managementKnee painBone marrowEdulla osseaMedical lifeHysician lifestyleEdical lifestyle

Researchers Target Genetic Influence on Asthma and Allergy

Indiana University lab received support from the National Institutes of Health to expand research on allergy risk factors.

Maine medical centerUnited statesJoan cookAnnec coatesNational institute of allergyIndiana university school of medicineNational instituteInfectious diseasesIndiana university schoolJoan cook millsMedscape medicalSevere asthmaUncontrolled asthmaAllergic rhinitisFood allergyFood hypersensitivity

Europe Approves Avapritinib for Rare Mast Cell Disease

The drug targets a mast cell mutation that gives rise to indolent systemic mastocytosis, a rare and debilitating blood disorder.

European unionEuropean commissionMedicinal productsHuman useRare diseasesLysosomal storage diseaseSystemic mastocytosisI cell diseaseUcolipidosis type iiNclusion cell diseaseUcolipidosis iiOl iiBone marrowEdulla ossea

vimarsana © 2020. All Rights Reserved.